METHOD FOR THE DETERMINATION OF THE DNA METHYLATION LEVEL OF A CPG POSITION IN IDENTICAL CELLS WITHIN A TISSUE SAMPLE
    1.
    发明公开
    METHOD FOR THE DETERMINATION OF THE DNA METHYLATION LEVEL OF A CPG POSITION IN IDENTICAL CELLS WITHIN A TISSUE SAMPLE 审中-公开
    VERFAHREN ZUR BESTIMMUNG DES DNA-METHYLIERUNGSGRADS EINER CPG-POSITION IN IDENTISCHEN ZELLEN IN EINER GEWEBEPROBE

    公开(公告)号:EP3095878A1

    公开(公告)日:2016-11-23

    申请号:EP16163903.4

    申请日:2006-11-17

    申请人: Epigenomics AG

    IPC分类号: C12Q1/68

    CPC分类号: C12Q1/6827

    摘要: Aspects of the present invention relate to the determination of the DNA methylation level at one or more CpG position within cells of a defined type in a tissue sample. This methylation level is deduced from the total DNA methylation level of all cells of the sample and from the content of said cells of interest. In aspects of the invention, the cell content is determined by means of histopatholoy, staining methods, antibodies, expression analysis or DNA methylation analysis.

    摘要翻译: 本发明的方面涉及在组织样品中限定类型的细胞内的一个或多个CpG位置处的DNA甲基化水平的确定。 该甲基化水平是从样品的所有细胞的总DNA甲基化水平以及所述感兴趣的细胞的含量推断的。 在本发明的方面,通过组织病理学,染色方法,抗体,表达分析或DNA甲基化分析来确定细胞含量。

    METHODS FOR DETECTING CPG METHYLATION OF TUMOR-DERIVED DNA IN BLOOD SAMPLES

    公开(公告)号:EP3828281A1

    公开(公告)日:2021-06-02

    申请号:EP20214665.0

    申请日:2017-01-27

    申请人: Epigenomics AG

    IPC分类号: C12Q1/68

    摘要: The present invention relates to the field of pharmacogenomics and in particular to detecting the presence or absence of methylated ANKRD13B and/or FOXF2 DNA derived from a tumor in blood or blood-derived samples or in other body fluids that contain DNA released from a tumor. This detection is useful for a minimally invasive diagnosis of cancers and the invention provides methods and oligonucleotides suitable for this purpose.